Chlamydia And Gonorrhea News

Chlamydia and gonorrhoea screening recommendations advise routine testing for sexually active women aged 24 and younger, and for women aged 25 or older when their risk is increased. Testing decisions should reflect sexual activity rather than age alone. Men and sexual partners may also need testing, while throat and rectal infections can require testing beyond the genital area.

Chlamydia And Gonorrhea News
Medically reviewed

Dr. Chrysoula I. Liakou MD, PhD Google Scholar LinkedIn

Internal Medicine Specialist
Cancer Immunology Researcher

 

What Everyone Should Know About Chlamydia and Gonorrhoea Testing

Have you ever wondered about the reasoning behind your doctor's selection of certain diseases to screen for? Interestingly, people with cervixes receive Pap tests at age 21, while most don't undergo mammograms until 40 and colonoscopies at 50. This screening process is heavily influenced by the U.S. Preventive Services Task Force, a group of physicians and public health experts who meticulously examine the available evidence and determine which screenings and other types of preventive healthcare exhibit proven benefits in reducing cancer deaths while causing minimal harm, such as false positives or follow-up tests that don't lead to measurably reduced risk.

 Why is this information important to you? Because the USPSTF (U.S. Preventive Services Task Force) updated its recommendations last fall concerning screenings for chlamydia and gonorrhoea. They confirmed that women 24 years old and younger should routinely be tested for these STIs and that testing should also be done for women 25 and older who are considered "at risk." Since these guidelines might seem ambiguous, our in-house STI expert explains what this should mean for you.



To STIs, Age Is Just A Number.


Regular testing for sexually transmitted infections (STIs) is crucial for maintaining sexual health. It is recommended that individuals aged 24 and younger prioritize testing due to higher rates of STIs in this age group. However, it is essential to note that testing should not be stopped once an individual turns 25 unless they are not sexually active or are in a monogamous relationship with a known partner. It is vital to base your testing schedule on your sexual activity, not age. STIs can affect anyone, regardless of age, so anyone sexually active must get tested regularly.

 


Men Need Testing Too.


STIs can result in scarring in the female reproductive tract and affect fertility. Women tend to be the primary focus regarding STIs; however, they often contract these infections from men. Men must get tested and treated to prevent them from re-infecting their partners. In cases of positive test results, it is crucial for all partners, regardless of gender, to get treated to avoid the STI from being passed back and forth.



Test Three Body Parts.


It is important to note that chlamydia and gonorrhoea can infect both the throat and rectum. Testing solely in the genital area may lead to missing these infections entirely. As recommended by Emily, three-site testing is highly encouraged to provide a more thorough and complete picture.



Don’t Stop With Two STIs.


While screening for STIs, also check for HIV and syphilis. Being at risk for one means being at risk for others.


Mobi Doctor offers a convenient, comfortable, and confidential way to get prescriptions for sexually transmitted infections (STIs)


With Mobi Doctor you get online urgent care.



Chlamydia and Gonorrhoea Testing FAQs

Routine screening is recommended for sexually active women aged 24 and younger. Women aged 25 or older should also be tested when their risk is increased. Age is only one factor; current sexual activity and possible exposure also matter. People of any gender may require testing if they have been exposed or a sexual partner receives a positive result.

Chlamydia and gonorrhoea testing is not only for women. Screening guidance often focuses on women because untreated infections can scar the reproductive tract and affect fertility, but men can carry and transmit both infections. Testing and treating men is particularly important following possible exposure or when a sexual partner tests positive.

Genital testing can miss an infection located in the throat or rectum. Chlamydia and gonorrhoea can affect all three sites, sometimes without being present in the genital area. Depending on the types of sexual contact involved, genital, throat and rectal samples may be needed to provide a more complete assessment.

Untreated chlamydia and gonorrhoea can affect fertility by causing infection and scarring within the female reproductive tract. This damage can interfere with normal reproductive function even when the original infection was not obvious. Early testing and appropriate treatment reduce the risk of the infection remaining undetected and causing avoidable complications.

Chlamydia and gonorrhoea can return if someone is exposed again after treatment. An untreated partner can pass the infection back, creating a cycle of reinfection between partners. Following a positive result, relevant sexual partners should also be tested and treated so that the infection is not repeatedly transmitted.

Testing for HIV and syphilis may be appropriate alongside chlamydia and gonorrhoea screening. The same sexual exposure can place someone at risk of more than one infection, although having one STI does not automatically mean another is present. Broader screening can identify infections that would otherwise remain undetected.

STI testing should reflect current sexual activity and exposure risk rather than age alone. Turning 25 does not mean screening should automatically stop. Continuing testing may be appropriate when someone has ongoing risk, while people who are not sexually active or are in a mutually monogamous relationship with a known tested partner may require a different schedule.


Comments

Submit


Swipe up to see a Dr.

close